Cynvenio Biosystems Joins Life Technologies’ Ion Certified Service Provider Program

Dec. 20, 2013 (Life Technologies Press Release) -- Life Technologies Corporation (NASDAQ: LIFE) announced that Cynvenio Biosystems, a molecular testing company focused on liquid biopsy assay development, has joined the Ion Certified Service Provider (CSP) program. Cynvenio’s LiquidBiopsy® technology is a proprietary platform for recovering circulating tumor cells at purity levels high enough to enable detection by next-generation sequencing.

Cynvenio Biosystems to Present Clinical Data on Mutational Analysis of LiquidBiopsy® Tumor Samples at the 2013 ASCO Annual Meeting

May 24, 2013 – Cynvenio announced that clinical data from two research collaborations in breast and prostate cancer will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2013 taking place May 31-June 4, 2013 in Chicago. These data highlight the company’s progress in the molecular analysis of circulating tumor cells (CTC) by next generation sequencing.